BECTON DICKINSON ACUTECARE, INC. – Trademark Portfolio

Entity Type: 03

BECTON DICKINSON ACUTECARE, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VISITEC and VISIDRAPE. The owner is based in FRANKLIN LAKES, NJ.

1 BECTON DRIVE

FRANKLIN LAKES, NJ 07417

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VISIDRAPE
VISIDRAPE
Registered 1997
VISITREC
VISITREC
Cancelled 1991
VISIFLEX
VISIFLEX
Cancelled 1987
VISITEC
VISITEC
Registered 1986
VISITEC
VISITEC
Cancelled 1982

Trademark Classifications

BECTON DICKINSON ACUTECARE, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does BECTON DICKINSON ACUTECARE, INC. have?

BECTON DICKINSON ACUTECARE, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does BECTON DICKINSON ACUTECARE, INC. file in?

BECTON DICKINSON ACUTECARE, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are BECTON DICKINSON ACUTECARE, INC.'s most well-known trademarks?

BECTON DICKINSON ACUTECARE, INC.'s registered trademark portfolio includes well-known marks such as VISITEC and VISIDRAPE. These are among 2 currently registered trademarks in the portfolio.

What is BECTON DICKINSON ACUTECARE, INC.'s trademark registration success rate?

BECTON DICKINSON ACUTECARE, INC. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.